Jazz Pharmaceuticals
JAZZ
#1491
Rank
S$18.47 B
Marketcap
S$284.61
Share price
-3.78%
Change (1 day)
59.00%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2026 (TTM): S$0.93 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are S$4.60 Billion. In 2025 the company made an earning of -S$0.81 Billion a decrease over its 2024 earnings that were of S$0.60 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$0.93 B-216.59%
2025 -S$0.81 Billion-233.49%
2024 S$0.60 B57.87%
2023 S$0.38 B-179.92%
2022 -S$0.48 Billion230.37%
2021 -S$0.15 Billion-141.02%
2020 S$0.35 B-39.45%
2019 S$0.58 B-14.2%
2018 S$0.67 B20.03%
2017 S$0.56 B-17.15%
2016 S$0.68 B22.14%
2015 S$0.55 B187.64%
2014 S$0.19 B-50.79%
2013 S$0.39 B73.63%
2012 S$0.22 B41.69%
2011 S$0.16 B116.61%
2010 S$73.93 M262.77%
2009 S$20.38 M-111.33%
2008 -S$0.18 Billion1.31%
2007 -S$0.18 Billion77.8%
2006 -S$99.87 Million36.59%
2005 -S$73.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
S$19.85 B 2,033.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AmerisourceBergen
ABC
S$2.68 B 188.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-S$3.07 Billion-428.69%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
S$2.05 B 120.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel